(S)-N-(1-(3-(4-(3-aminopropylamino)butylamino)propylamino)-3-(4-hydroxyphenyl)-1-oxopropan-2-yl)cyclohexanecarboxamide

ID: ALA4556075

PubChem CID: 14806309

Max Phase: Preclinical

Molecular Formula: C26H45N5O3

Molecular Weight: 475.68

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  NCCCNCCCCNCCCNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)C1CCCCC1

Standard InChI:  InChI=1S/C26H45N5O3/c27-14-6-17-28-15-4-5-16-29-18-7-19-30-26(34)24(20-21-10-12-23(32)13-11-21)31-25(33)22-8-2-1-3-9-22/h10-13,22,24,28-29,32H,1-9,14-20,27H2,(H,30,34)(H,31,33)/t24-/m0/s1

Standard InChI Key:  AKHCKCPDLAYHDW-DEOSSOPVSA-N

Molfile:  

 
     RDKit          2D

 34 35  0  0  0  0  0  0  0  0999 V2000
    5.6460  -17.8544    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3579  -17.4458    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.9342  -17.4458    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2224  -17.8544    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.2224  -18.6757    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5105  -19.0884    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9342  -19.0884    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.9342  -16.6245    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2224  -16.2118    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2254  -15.3894    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5144  -14.9809    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8015  -15.3895    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8083  -16.2150    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5157  -16.6240    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0933  -14.9818    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.0697  -17.8544    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7816  -17.4458    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4893  -17.8544    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.2011  -17.4458    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.9129  -17.8544    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.6248  -17.4458    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.3366  -17.8544    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.0484  -17.4458    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.7603  -17.8544    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   13.4721  -17.4458    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.1798  -17.8544    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.8917  -17.4458    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.6035  -17.8544    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.6460  -18.6757    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.8018  -18.6774    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0962  -19.0867    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0920  -19.9083    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7996  -20.3191    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5155  -19.9124    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  5  7  2  0
  3  8  1  1
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14  9  1  0
 12 15  1  0
  2 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
  1 29  2  0
  6 30  1  0
  6 34  1  0
 30 31  1  0
 31 32  1  0
 32 33  1  0
 33 34  1  0
M  END

Associated Targets(Human)

CHRNB4 Tclin Neuronal acetylcholine receptor; alpha3/beta4 (2283 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CHRNB2 Tclin Neuronal acetylcholine receptor; alpha4/beta2 (3972 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 475.68Molecular Weight (Monoisotopic): 475.3522AlogP: 1.81#Rotatable Bonds: 17
Polar Surface Area: 128.51Molecular Species: BASEHBA: 6HBD: 6
#RO5 Violations: 1HBA (Lipinski): 8HBD (Lipinski): 7#RO5 Violations (Lipinski): 1
CX Acidic pKa: 9.41CX Basic pKa: 10.76CX LogP: -0.04CX LogD: -5.01
Aromatic Rings: 1Heavy Atoms: 34QED Weighted: 0.19Np Likeness Score: -0.23

References

1. Kachel HS, Franzyk H, Mellor IR..  (2019)  Philanthotoxin Analogues That Selectively Inhibit Ganglionic Nicotinic Acetylcholine Receptors with Exceptional Potency.,  62  (13): [PMID:31244109] [10.1021/acs.jmedchem.9b00519]

Source